pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Multiple Ascending Doses Study of CG400549
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: CG400549 640mg|DRUG: CG400549 320 mg|DRUG: CG400549 640 mg|DRUG: CG400549 960 mg|DRUG: Placebo 640mg|DRUG: Placebo 320mg|DRUG: placebo 960 mg|DRUG: Placebo 640mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study for Post op Inflammation After Cataract Surgery
Status: ENROLLING_BY_INVITATION
Conditions: Cataract
Interventions: DRUG: Dextenza 0.4Mg Ophthalmic Insert|DRUG: Prednisolone Acetate 1%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients
Status: COMPLETED
Conditions: Pulmonary Tuberculosis
Interventions: DRUG: A. 100,000 IU Cholecalciferol per dose of 3.3ml|OTHER: B. Migliol Oil without Cholecalciferol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery
Status: UNKNOWN
Conditions: Wet Macular Degeneration|Cataract Extraction
Interventions: DRUG: Ranibizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of GPOEM in the Treatment of Gastroparesis
Status: NOT_YET_RECRUITING
Conditions: Gastroparesis|Gastroparesis Postoperative|Gastroparesis With Diabetes Mellitus
Interventions: PROCEDURE: GPOEM - gastric per-oral endoscopic myotomy
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: CHildren Treated With Vincristine: A Trial Regarding Pharmacokinetics, DNA And Toxicity of Targeted Therapy In Pediatric Oncology Patients.
Status: RECRUITING
Conditions: Pediatric Cancer
Interventions: DRUG: Vincristine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis
Status: ACTIVE_NOT_RECRUITING
Conditions: Malignant Peritoneal Neoplasm|Malignant Retroperitoneal Neoplasm|Metastatic Cervical Carcinoma|Metastatic Endometrial Carcinoma|Metastatic Fallopian Tube Carcinoma|Metastatic Malignant Female Reproductive System Neoplasm|Metastatic Ovarian Carcinoma|Metastatic Primary Peritoneal Carcinoma|Peritoneal Carcinomatosis|Platinum-Refractory Fallopian Tube Carcinoma|Platinum-Refractory Malignant Female Reproductive System Neoplasm|Platinum-Refractory Ovarian Carcinoma|Platinum-Refractory Primary Peritoneal Carcinoma|Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Malignant Female Reproductive System Neoplasm|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Recurrent Cervical Carcinoma|Recurrent Endometrial Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Malignant Female Reproductive System Neoplasm|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Stage IV Fallopian Tube Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Primary Peritoneal Cancer AJCC v8|Stage IVA Fallopian Tube Cancer AJCC v8|Stage IVA Ovarian Cancer AJCC v8|Stage IVA Primary Peritoneal Cancer AJCC v8|Stage IVB Cervical Cancer AJCC v8|Stage IVB Fallopian Tube Cancer AJCC v8|Stage IVB Ovarian Cancer AJCC v8|Stage IVB Primary Peritoneal Cancer AJCC v8|Stage IVB Uterine Corpus Cancer AJCC v8
Interventions: BIOLOGICAL: Ipilimumab|OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Nivolumab|OTHER: Pharmacokinetic Study
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers
Status: COMPLETED
Conditions: Pancreatic Adenocarcinoma Metastatic|Ovarian Serous Adenocarcinoma|Colorectal Cancer Metastatic
Interventions: DRUG: Plerixafor
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Chronic Evaluation of Respicardia Therapy
Status: COMPLETED
Conditions: Sleep Disordered Breathing|Cheyne Stokes Respiration|Periodic Breathing|Sleep Apnea|Central Sleep Apnea
Interventions: DEVICE: remedē (TM) system
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Enhancing Exposure Therapy for Snake and Spider Phobias
Status: COMPLETED
Conditions: Specific Phobia
Interventions: BEHAVIORAL: Exposure Therapy with Retrieval|BEHAVIORAL: Exposure Therapy with Compound Extinction|BEHAVIORAL: Exposure Therapy with Retrieval and Compound Extinction|BEHAVIORAL: Therapist-guided Exposure Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Status: UNKNOWN
Conditions: Shock Hypovolemic|Shock, Septic|Blood Transfusion|Adrenaline|Dopamine
Interventions: DRUG: Dopamine|DRUG: adrenaline|DRUG: Blood Transfusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 68Ga-DOTATATE PET for Management of Neuroendocrine Tumors
Status: COMPLETED
Conditions: Neuroendocrine Tumors
Interventions: DIAGNOSTIC_TEST: 68Ga -DOTATATE PET scans
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
Status: COMPLETED
Conditions: Metastatic Melanoma
Interventions: BIOLOGICAL: Allovectin-7®|DRUG: Dacarbazine (DTIC)|DRUG: Temozolomide (TMZ)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Randomized Study of Radiofrequency- vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial Flutter
Status: UNKNOWN
Conditions: Atrial Flutter
Interventions: PROCEDURE: RF ablation of the cavo-tricuspid isthmus|PROCEDURE: cryo ablation of the cavo-tricuspid isthmus|PROCEDURE: irrigated tip radiofrequency ablation of the cavo-tricuspid isthmus|PROCEDURE: cryo 6.5mm tip ablation of the cavotricuspid isthmus
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Randomised Controlled Trial of Needle Free Access Devices in Preventing Hemodialysis Blood Stream Infection
Status: UNKNOWN
Conditions: Hemodialysis Catheter Blood Stream Infection|Central Line Infection|Dialysis Line Thrombosis
Interventions: DEVICE: TEGO|DEVICE: Standard
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367
Status: COMPLETED
Conditions: Malaria,Falciparum
Interventions: DRUG: MMV367|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Marijuana on Neuropathic Pain and Spasticity in Spinal Cord Injury Patients
Status: ENROLLING_BY_INVITATION
Conditions: Spinal Cord Injury
Interventions: DRUG: Cannabis|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care
Status: COMPLETED
Conditions: Musculoskeletal Injury|Pain, Chronic|Pain, Acute|Sport Injury|Soft Tissue Injuries|Arm Injury|Back Pain|Tendon Injuries|Muscle Injury
Interventions: DEVICE: Continuous Ultrasound
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Ultrasound-Guided Percutaneous Neuromodulation in the Strength of CrossFit Athletes: A RCT
Status: NOT_YET_RECRUITING
Conditions: Healthy|CrossFit
Interventions: OTHER: NMP-e
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sildenafil for Prevention of Cerebral Vasospasm
Status: WITHDRAWN
Conditions: Subarachnoid Hemorrhage|Cerebral Vasospasm|Rupture of Intracranial Aneurysm
Interventions: DRUG: Placebo|DRUG: Sildenafil Citrate, 25 mg, 3 times a day.|DRUG: Sildenafil Citrate 50 mg, 3 times a day
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Cardiac Safety of Lansoprazole and Domperidon Combination
Status: WITHDRAWN
Conditions: GERD|Cardiac Event|Safety Issues
Interventions: COMBINATION_PRODUCT: Lansoprazole/Domperidone|DRUG: Lansoprazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING
Clinical trial: Impact of GBS on CVD in Type 2 Diabetes Mellitus
Status: COMPLETED
Conditions: Obesity|Type 2 Diabetes Mellitus
Interventions: OTHER: Diabetes Support and Education|PROCEDURE: gastric bypass surgery|OTHER: Tissue Control Group
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Investigate the Efficacy and Effectiveness of Aromatherapy for the Management of Behavioral and Psychological Symptoms of Dementia
Status: COMPLETED
Conditions: Dementia
Interventions: OTHER: aromatherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pharmacogenomics IND EXEMPT SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms
Status: ACTIVE_NOT_RECRUITING
Conditions: Prostate Cancer
Interventions: DRUG: Abiraterone - Usual|DRUG: Abiraterone - Study
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve
Status: COMPLETED
Conditions: Endometrioma
Interventions: PROCEDURE: Laparoscopic ovarian cystectomy|PROCEDURE: laparoscopic cyst deroofing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Phase II Study to Evaluate the Efficacy of AMG 317
Status: COMPLETED
Conditions: Asthma
Interventions: BIOLOGICAL: AMG 317 75 mg|BIOLOGICAL: AMG 317 150 mg|BIOLOGICAL: AMG 317 300 mg|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Proprioception, Touch and Psychometric Relationship in Volleyball Players
Status: COMPLETED
Conditions: Proprioceptive Disorders|Sports Physical Therapy|Kinesiophobia|Somatosensory Disorders|Shoulder Injuries
Interventions: DIAGNOSTIC_TEST: Shoulder Proprioception, Palmar Touch Sensation and Psychometric Parameters
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: GE-145 (AN113111) Injection|DRUG: Visipaque (iodixanol) Injection
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV
Status: UNKNOWN
Conditions: Pediatric HIV Infection
Interventions: DRUG: DTG DT 20 mg|DRUG: DTG DT 25 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
Status: RECRUITING
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: Tucatinib in Combination of Oral VP16 and trastuzumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC
Status: TERMINATED
Conditions: Non-small Cell Lung Cancer
Interventions: DRUG: PEGylated recombinant human hyaluronidase PH20|DRUG: Docetaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Ashtanga-Vinyasa Yoga Supta on Portuguese Airforce Military Pilots Performance
Status: ACTIVE_NOT_RECRUITING
Conditions: Military Operational Stress Reaction
Interventions: OTHER: Ashtanga Vinyasa Yoga Supta
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Digital vs Conventional Impression in Capturing the Emergence Profile Around Maxillary Anterior Implant-supported Crowns
Status: RECRUITING
Conditions: Dental Implants, Single-Tooth|Dental Impression Technique
Interventions: PROCEDURE: indirect digital impression and 3D printed cast|PROCEDURE: direct digital impression|PROCEDURE: conventional impresion and cast
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Patient Satisfaction With AQUACEL® Ag Surgical Dressing Compared to Standard Surgical Dressing
Status: COMPLETED
Conditions: Wound Healing
Interventions: PROCEDURE: Postop Dressing|PROCEDURE: Postop Dressing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Glucolipotoxicity and Type 2 Diabetes
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus
Interventions: PROCEDURE: Glucotoxicity|PROCEDURE: Lipotoxicity
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
Status: COMPLETED
Conditions: Rectal Cancer|Low Anterior Resection Syndrome
Interventions: BEHAVIORAL: LARS score/ EORTC QLQ C30
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Status: COMPLETED
Conditions: Oligoastrocytoma, Mixed|Anaplastic Oligodendroglioma
Interventions: DRUG: Temozolomide
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
Status: COMPLETED
Conditions: Breast Cancer|Breast Cancer Stage|Breast Cancer Stage I|Breast Cancer Stage II|Breast Cancer Stage III|Breast Cancer Stage IV
Interventions: DRUG: Triamcinolone Acetonide|DRUG: Oleogel-S10
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere
Status: COMPLETED
Conditions: Uterine Myoma|Uterine Fibroid
Interventions: DEVICE: Gelatin microsphere (Nexsphere™)|DEVICE: Embosphere
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
Status: COMPLETED
Conditions: Post Traumatic Stress Disorder
Interventions: DRUG: Brexpiprazole|DRUG: Sertraline|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
Status: RECRUITING
Conditions: Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|HER2 Negative Breast Carcinoma|Hormone Receptor Positive Breast Carcinoma|Invasive Breast Carcinoma|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8
Interventions: OTHER: Educational Intervention|OTHER: Text Message-based Navigation Intervention|BEHAVIORAL: Motivational Interviewing|OTHER: Best Practice|OTHER: Questionnaire Administration|OTHER: Quality-of-Life Assessment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm
Status: COMPLETED
Conditions: Cerebral Vasospasm|Subarachnoid Hemorrhage
Interventions: OTHER: Rhythmic tolerance|OTHER: Hematological tolerance|OTHER: Milrinone efficiency on cerebral vasospasm|OTHER: Milrinone efficiency using the modified Rankin scale
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Comparison of the Effect of Spine Grade I and II Manipulation and a PNE Video on Brainwaves: Pilot Study
Status: COMPLETED
Conditions: Chronic Pain|Manipulation|Psychologic
Interventions: BEHAVIORAL: Understanding Pain in less than 5 minutes, and what to do about it! https://www.youtube.com/watch?v=C_3phB93rvI|PROCEDURE: PA manipulation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: BIBR 796 BS, low dose|DRUG: BIBR 796 BS, high dose|DRUG: Placebo|DRUG: Lipopolysaccharide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure
Status: COMPLETED
Conditions: Heart Failure
Interventions: OTHER: Aerobic-Resistance-Inspiratory|OTHER: Aerobic-Resistance|OTHER: Aerobic-Inspiratory|OTHER: Aerobic Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Tolerability Study of an Edible Colon Preparation
Status: COMPLETED
Conditions: Bowel Preparation
Interventions: DRUG: NuLYTELY® (PEG 3350)|DRUG: ECP-019|DRUG: MoviPrep® (PEG 3350)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Pharmacist Led Educational Intervention on QOL, Medication Adherence & Satisfaction on Patients With Type 1 DM
Status: RECRUITING
Conditions: Diabetes Mellitus, Type 1
Interventions: OTHER: Educational intervension
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers
Status: COMPLETED
Conditions: Ebola Vaccine
Interventions: BIOLOGICAL: INO-4201|BIOLOGICAL: INO-4202|BIOLOGICAL: INO-4201|BIOLOGICAL: INO-4212|BIOLOGICAL: INO-4212 + INO-9012|BIOLOGICAL: INO-4201 + INO-9012
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Project 4A: Inspiratory Muscle Training and Diaphragm Strength
Status: TERMINATED
Conditions: Sepsis
Interventions: PROCEDURE: Bilateral phrenic nerve stimulation and measurement of transdiaphragmatic pressure|DRUG: Midazolam|PROCEDURE: Volitional Measurement of Maximal Inspiratory Pressure (MIP)|DEVICE: Inspiratory Muscle Strength Training (IMST)|DEVICE: SHAM Inspiratory Muscle Strength Training (IMST)|PROCEDURE: Diaphragm thickness measurement|OTHER: Blood and Urine samples
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study
Status: COMPLETED
Conditions: Hemianopia|Stroke
Interventions: DEVICE: verum tDCS|DEVICE: sham tDCS|BEHAVIORAL: VRT
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia
Status: RECRUITING
Conditions: Acute Promyelocytic Leukemia
Interventions: DRUG: Oral arsenic Trioxide, ATRA and ascorbic acid
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: An Early Phase 2 Clinical Study of KSP-0243
Status: ACTIVE_NOT_RECRUITING
Conditions: Colitis, Ulcerative
Interventions: DRUG: KSP-0243|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.
Status: ACTIVE_NOT_RECRUITING
Conditions: Partial Seizure
Interventions: DRUG: Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)|DRUG: Brivaracetam sustained-release tablets 100mg|DRUG: Brivaracetam sustained-release tablets 50mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis
Status: COMPLETED
Conditions: Liver Fibrosis|Liver Steatosis
Interventions: DEVICE: Liver Incyte
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Bevacizumab Against Recurrent Retinal Detachment
Status: COMPLETED
Conditions: Retinal Detachment|Proliferative Vitreoretinopathy
Interventions: DRUG: Bevacizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease
Status: UNKNOWN
Conditions: Atherosclerosis
Interventions: DIETARY_SUPPLEMENT: R-alpha lipoic acid
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Becker Continued Access Study
Status: TERMINATED
Conditions: Breast Reconstruction
Interventions: DEVICE: Mentor Becker 25 Expander/Breast Implant|DEVICE: Mentor Becker 50 Expander/Breast Implant
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis
Status: RECRUITING
Conditions: Rheumatoid Arthritis
Interventions: DRUG: autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Status: UNKNOWN
Conditions: Nasopharyngeal Carcinoma
Interventions: DRUG: Sintilimab in combination with Multimodality Radiotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
Status: ACTIVE_NOT_RECRUITING
Conditions: Advanced Head and Neck Squamous Cell Carcinoma|Advanced Breast Cancer|Advanced Melanoma
Interventions: DRUG: CyPep-1|DRUG: Pembrolizumab 25 MG/ML [KEYTRUDA®]
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Gastrostomy Tube Coated With Povidone-iodine for Reducing Peristomal Infection Rate After PEG Insertion
Status: UNKNOWN
Conditions: Infection
Interventions: OTHER: Povidone iodine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics
Status: COMPLETED
Conditions: Human Immunodeficiency Virus Type 1
Interventions: DRUG: Rilpivirine (RPV)|DRUG: Rilpivirine Long-Acting Parenteral Formulation (RPV-LA)|DRUG: Aged RPV-LA
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Acupuncture for Insomnia: a Randomized Controlled Trial
Status: UNKNOWN
Conditions: Sleep Initiation and Maintenance Disorders
Interventions: OTHER: DU20 and HT7 combination|OTHER: DU20 and SP6 combination|OTHER: DU20 and SA combination
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: ACT-128800 in Psoriasis
Status: COMPLETED
Conditions: Plaque Psoriasis
Interventions: DRUG: ACT-128800|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: RIRS for Treatment of Stones in Congenital Anomalous Kidneys
Status: UNKNOWN
Conditions: Renal Calculi|Renal Anomaly
Interventions: DEVICE: RIRS|DEVICE: SWL
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Status: NOT_YET_RECRUITING
Conditions: Alzheimer Disease
Interventions: DRUG: Donanemab|DRUG: Usual Care
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effect of the Consumption of a Probiotic Strain on the Prevention of Post-operative Recurrence in Crohn's Disease
Status: COMPLETED
Conditions: Crohn's Disease
Interventions: OTHER: 1-Freeze-dried Probiotics provided in capsule (150 mg) containing 1,0x10E10 colony forming unit per capsule (test)|OTHER: 2- excipients (150 mg) in capsule (control)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose:
Clinical trial: LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
Status: COMPLETED
Conditions: Non-Small Cell Lung Cancer
Interventions: DRUG: LDK378
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
Status: TERMINATED
Conditions: Solid Tumor
Interventions: DRUG: KITE-718|DRUG: Cyclophosphamide|DRUG: Fludarabine|DEVICE: MAGE - A3/A6 Screening Test
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells
Status: UNKNOWN
Conditions: Chronic Graft-Versus-Host Disease
Interventions: BIOLOGICAL: Mesenchymal Stromal Cells
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Randomized Control Trial on Postoperative Weight Bearing After High Tibial Osteotomy (HTO)
Status: COMPLETED
Conditions: Osteoarthritis, Knee
Interventions: PROCEDURE: Early weight bearing|PROCEDURE: Delayed weight bearing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: A Study of JNJ-64304500 in Participants With Alopecia Areata
Status: WITHDRAWN
Conditions: Alopecia Areata
Interventions: DRUG: JNJ-64304500|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris
Status: COMPLETED
Conditions: Acne Vulgaris
Interventions: DEVICE: Sebacia Microparticles|DEVICE: Nd:Yag Laser
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Status: TERMINATED
Conditions: Dental Restoration Failure of Marginal Integrity|Dental Caries|Unrepairable Overhanging of Dental Restorative Materials|Poor Aesthetics of Existing Restoration|Secondary Dental Caries Associated With Failed or Defective Dental Restorations|Fractured Dental Restorative Materials Without Loss of Materials|Fracture of Dental Restorative Materials With Loss of Material
Interventions: DEVICE: Filtek Bulk Fill Posterior|DEVICE: Filtek Supreme Ultra
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Concentrated Growth Factor Versus Platelet Rich Fibrin in Revitalization of Necrotic Young Permanent Incisors
Status: UNKNOWN
Conditions: Necrotic Pulp
Interventions: PROCEDURE: revitalization by concentrated growth factor
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
Status: RECRUITING
Conditions: B-cell Lymphoma|Burkitt Lymphoma|Diffuse Large B Cell Lymphoma|Follicular Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Transformed Non-Hodgkin Lymphoma|Richter Syndrome|Hodgkin Lymphoma
Interventions: DRUG: Polatuzumab vedotin
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Post Market Clinical Follow-Up for ED Coil / Electro-detach Generator v4
Status: UNKNOWN
Conditions: Aneurysm|Arteriovenous Malformations|Arterio-venous Fistula
Interventions: DEVICE: ED Coil / Electro-detach Generator v4
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer
Status: WITHDRAWN
Conditions: Prostate Cancer Metastatic
Interventions: DRUG: Actinium-J591|RADIATION: Stereotactic Body Radiation Therapy|DRUG: Androgen Deprivation Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase I Clinical Trial of AK115 in Healthy Subjects
Status: UNKNOWN
Conditions: Healthy Volunteers
Interventions: DRUG: AK115|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Co-administration of Saxagliptin and Metformin IR, Fasted|DRUG: Saxagliptin/Metformin, Fasting|DRUG: Co-administration of Saxagliptin and Metformin IR, Fed|DRUG: Saxagliptin/Metformin, Fed
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose:
Clinical trial: Effect of Periodontal Treatment on Salivary and Serum Biomarkers in Periodontitis
Status: COMPLETED
Conditions: Periodontal Health|Periodontitis
Interventions: PROCEDURE: Non-surgical periodontal treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Status: COMPLETED
Conditions: Metastatic Breast Cancer Starting a Third Line Chemotherapy
Interventions: OTHER: Construction of a prognostic score (non-drug intervention types)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: The Effect of a Computer-Assisted Rehabilitation Program on Epilepsy Patient
Status: ENROLLING_BY_INVITATION
Conditions: Epilepsy|Computer-assisted Cognitive Rehabilitation|Quality of Life
Interventions: OTHER: Application of computer-assisted cognitive rehabilitation program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Clinical Trial to Assess the Efficacy and Safety of a Novel Cellulite Cream
Status: COMPLETED
Conditions: Thigh Cellulite
Interventions: OTHER: Cellulite reduction cream
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
Status: COMPLETED
Conditions: Hidradenitis Suppurativa|Hidradenitis|Acne Inversa|Boils|Follicular Occlusion Triad|Follicular Occlusion Tetrad
Interventions: DRUG: Hydroxychloroquine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)
Status: COMPLETED
Conditions: Hepatitis C, Chronic
Interventions: BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031)|BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031)|DRUG: REBETOL (ribavirin; SCH 18908)|BIOLOGICAL: PEGASYS (peginterferon alfa-2a)|DRUG: COPEGUS (ribavirin)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
Status: COMPLETED
Conditions: Pulmonary Hypertension
Interventions: DRUG: UT-15C
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
Status: COMPLETED
Conditions: Stem Cell Transplantation|Leukemia
Interventions: DRUG: Plerixafor|DRUG: Filgrastim|DRUG: Fludarabine|DRUG: Busulfan|PROCEDURE: Allogeneic blood stem cell transplant|DRUG: ATG (Thymoglobulin)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain
Status: COMPLETED
Conditions: Pain
Interventions: DRUG: 1% diclofenac sodium plus 3% menthol|DRUG: 1% diclofenac sodium plus 0.09% menthol|DRUG: 3% menthol|DRUG: Placebo with 0.09% menthol gel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Global Assessment of Endoscopic Ultrasound Performance Skills
Status: COMPLETED
Conditions: E01.370.350.850.280|I02.399|J01.897.608|N06.850.135.060.075.399|F02.784.629.529.274
Interventions: OTHER: No intervention
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Status: TERMINATED
Conditions: Acute Erythroid Leukemia|Acute Lymphoblastic Leukemia|Acute Megakaryoblastic Leukemia|Acute Myeloid Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid Cell Neoplasm|HIV Infection|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts|Non-Hodgkin Lymphoma|Refractory Anemia
Interventions: DRUG: Fludarabine|DRUG: Cyclophosphamide|DRUG: Thiotepa|RADIATION: Total-Body Irradiation|PROCEDURE: Umbilical Cord Blood Transplantation|BIOLOGICAL: Dilanubicel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)
Status: COMPLETED
Conditions: Non Alcoholic Steatohepatitis
Interventions: PROCEDURE: AHA diet plus exercise with BIB placement|PROCEDURE: AHA diet plus exercise with sham BIB placement
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage
Status: NOT_YET_RECRUITING
Conditions: Postpartum Hemorrhage
Interventions: DEVICE: CELOX™ PPH
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy
Status: NOT_YET_RECRUITING
Conditions: Locally Advanced Cervical Carcinoma
Interventions: RADIATION: Hypofractionation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
Status: COMPLETED
Conditions: Brain and Central Nervous System Tumors
Interventions: OTHER: fluorine F 18 fluorothymidine|PROCEDURE: positron emission tomography
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Understanding Physiology During Float-REST and the Consequential Effects on Subjective and Objective Recovery
Status: COMPLETED
Conditions: Sleep Quality
Interventions: OTHER: Flotation therapy sensory deprivation tank|OTHER: Sleep Pod
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
Status: COMPLETED
Conditions: Hypertension
Interventions: DRUG: LCZ696|DRUG: Valsartan|DRUG: AHU377|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days
Status: COMPLETED
Conditions: HIV-1 Infection
Interventions: DRUG: Bevirimat
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC
Status: UNKNOWN
Conditions: Transarterial Chemoembolization|Hepatocellular Carcinoma
Interventions: DRUG: cTACE-HAIC
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial
Status: COMPLETED
Conditions: Toxic-Shock Syndrome|Sepsis
Interventions: BIOLOGICAL: rTSST-1 Variant Candidate Vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effect of Education and Tele-consultancy Intervention Based on Watson Human Care Theory Individuals With COPD
Status: COMPLETED
Conditions: Chronic Obstructive Pulmonary Disease|Self Efficacy|Quality of Life|Pulmonary Function|Nurse's Role
Interventions: BEHAVIORAL: education and tele-consultation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Radial Nerve Mobilization in Hand Thumb Osteoarthritis Patients
Status: COMPLETED
Conditions: Osteoarthritis Thumb|Joint Diseases|Radial Neuropathy
Interventions: OTHER: routine therapy|OTHER: radial nerve mobilization exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Virtual cOaching in Making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
Status: COMPLETED
Conditions: Elder Abuse
Interventions: BEHAVIORAL: Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
Status: ACTIVE_NOT_RECRUITING
Conditions: Myelofibrosis
Interventions: DRUG: GB2064
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Staging System for Chronic Symptomatic Pilonidal Sinus Disease
Status: COMPLETED
Conditions: Pilonidal Sinus
Interventions: PROCEDURE: pit-picking technique|PROCEDURE: Bascom Cleft Lift|PROCEDURE: Rhomboid excision with the Limberg Flap|PROCEDURE: Other flap techniques
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis
Status: COMPLETED
Conditions: Multiple Sclerosis
Interventions: BIOLOGICAL: recombinant human alpha B-crystallin|OTHER: Placebo comparator
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers
Status: UNKNOWN
Conditions: Urethral Stricture
Interventions: PROCEDURE: Urethroplasty with a tissue-engineered construct
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
Status: RECRUITING
Conditions: Laryngeal Dystonia|Spasmodic Dysphonia|Tremor
Interventions: OTHER: Brain imaging|DRUG: Laryngeal sensory block with topical bupivacaine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Safety and Immunogenicity of a Live-attenuated Vaccine Against Respiratory Syncytial Virus in Elderly Volunteers
Status: COMPLETED
Conditions: Respiratory Syncytial Virus Infections
Interventions: BIOLOGICAL: CodaVax-RSV|BIOLOGICAL: Normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: PREVENTION
Clinical trial: A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: TERMINATED
Conditions: Atopic Dermatitis
Interventions: DRUG: Baricitinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Predictability of the Pulse Pressure Variation (PPV) During Spontaneous Ventilation on the Incidence of Hypotension During Induction of Anesthesia
Status: UNKNOWN
Conditions: Hypotension
Interventions: OTHER: PPV>14%|DRUG: Volume loading|OTHER: PPV<14%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Effect of rTMS on the Abnormal Executive Function of ASD Children
Status: UNKNOWN
Conditions: Executive Dysfunction|ASD
Interventions: DEVICE: Active cTBS|DEVICE: Sham
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
Status: UNKNOWN
Conditions: Breast Cancer
Interventions: DRUG: dtEC→dtT|DRUG: FEC→T
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT